OROsbaldo Resendis-Antonio

Osbaldo Resendis-Antonio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Osbaldo Resendis-Antonio has a total of 298 co-authors. Here are the top co-authors by number of shared publications:

  • Aarón Vázquez-Jiménez

    Human Systems Biology Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico

    12 shared publications
  • Aarón Vázquez-Jiménez

    Human Systems Biology Laboratory, National Institute of Genomic Medicine, Mexico City 14610, Mexico

    10 shared publications
  • Daniel Neri-Rosario

    Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico

    8 shared publications
  • Christian Diener

    Diagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria

    7 shared publications
  • Cristian Padron-Manrique

    INMEGEN) Programa de Doctorado en Ciencias Biomédicas Human Systems Biology Laboratory Instituto Nacional de Medicina Genómica ( Universidad Nacional Autónoma de México (UNAM) Mexico City Mexico

    7 shared publications
  • Jean Paul Sánchez-Castañeda

    Human Systems Biology Laboratory. Instituto Nacional de Medicina Genómica (INMEGEN), México City, Mexico

    7 shared publications

Latest Publications

  • Open Access

    Cyclin-Dependent Kinase Inhibitor 1A Betrays Early Liver Damage Driving Cancer: A Pilot Study

    by Ari Sánchez-Padilla, Amairani Escorcia-Barrera, Marco Antonio Tafoya-Olvera, Alejandra Idan Valencia-Cruz, José Luis García-Meza, Brisa Rodope Alarcón-Sánchez, Osiris Germán Idelfonso-García, Linda Vanessa Márquez-Quiroga, Julia Esperanza Torres-Mena, Sergio Fuentes-Hernández, et al.

    Hepatocellular carcinoma (HCC) progresses asymptomatically over several decades after chronic exposure to multiple hepatotoxins. Here, we aimed to identify molecules revealing the malignant onset and progression of liver diseases. From a transcriptomic analysis of a HCC mouse model, ingenuity pathway analysis (IPA) was used to determine the involved causal signaling networks, and relevant genes were validated to identify early biomarkers. The relevant findings were validated in the blood of high-fat diet, alcohol-associated liver disease (ALD), and metabolic dysfunction-associated steatotic liver disease (MASLD) in vivo models, as well as in ALD patients. Ten IPA-predicted causal signaling networks were associated with HCC progression. The expression of cyclin-dependent kinase inhibitor 1a (Cdkn1a) gene, commonly known as P21, was the most dysregulated, and its total (CDN1A/P21) and phosphorylated protein level was increased from early to late stages. P21 was also increased and released into the bloodstream of ALD and MASLD models, both based on multiple hepatotoxins linked to HCC development, as well as in the bloodstream of ALD patients. In conclusion, P21 is altered from early stages of liver diseases leading to HCC, which betrays the onset of liver cancer before developing malignant traits; thus, P21 offers a critical therapeutic window for timely detection of high-risk patients.

  • Open Access

    Identification of Markers on the Basis of Transcriptomic Analysis for Molecular Assignment of Medulloblastoma

    by Sergio Juárez-Méndez, Aarón Vázquez-Jiménez, Josselen Carina Ramírez-Chiquito, Vanessa Villegas-Ruíz, Ana Maria Niembro-Zuñiga, José Eduardo Farfán-Morales, Alfonso Marhx-Bracho, Edgar Krötzsch, Miguel Rodríguez-Morales, Emma Segura-Solís, et al.

    Medulloblastoma is a heterogeneous solid tumor, and its molecular characteristics are the most important prognostic factors for this neoplasm. Unfortunately, the molecular classification of MB-G3 and MB-G-4 medulloblastoma is very complex because of molecular similarity. Therefore, in this work, through unsupervised machine learning-based gene expression profiling, we identified a low molecular profile associated with four molecular groups of medulloblastoma. We performed medulloblastoma expression microarray data mining via the Partek Genomics Suite and Transcriptome Analysis Console (TAC), and we included a total of 25 fresh medulloblastoma tumors that were obtained and hybridized into HG U133 Plus 2.0 Array microarrays. To identify the molecular groups of the 25 patients, we compared them against classified patients, which were obtained from free repositories, and through data mining based on gene expression, compared the expression profiles of our patients. To do so, we performed an analysis via the least squares method via PCA. The molecular groups MB-WNT and MB-SHH were confirmed via immunohistochemistry via β-catenin, YAP1 and GAB1 antibodies in tissue fixed in formalin and embedded in paraffin, and another tissue section was placed on a Visium Spatial slide to perform spatial RNA-seq via Illumina NextSeq 2000 platform sequencers. The data obtained were analyzed with R. We identified the expression profiles associated with the four molecular groups and formed a reference set. Through unsupervised analysis via the least squares method, we assigned the molecular profiles of 25 patients with medulloblastoma, via the integration of bulk and spatial tumor molecular gene expression profiling analysis and with immunohistochemical findings, this strategy was fast and accurate. We observed correlations in three of the trials carried out and, in part, in one study, a patient who presented two tumor strains and two molecular signatures (SHH and G4), which led us to believe that this patient presented mixed phenotypic characteristics. Multigene expression profile analysis of medulloblastoma represents a significant advance in precision medicine; integrating different layers of transcriptomic information allows us to demonstrate underlying molecular changes in the four molecular groups that are essential for personalized therapy.

  • Open Access

    Digital modeling of metformin and diet interactions on gut-microbiota metabolism in prediabetic patients

    by Juan José Oropeza-Valdez, Cristian Padron-Manrique, Jorge E. Arellano-Villavicencio, Aarón Vázquez-Jiménez, Laura E. Hernández-Juárez, Xavier Soberon, María de Lourdes Reyes-Escogido, Rodolfo Guardado-Mendoza, Osbaldo Resendis-Antonio

    Prediabetes confers a high risk of progressing to type 2 diabetes mellitus (T2DM). While metformin, a first-line T2DM therapy, improves glycemic control in prediabetes, its effects on the gut microbiota and host metabolic shifts remain poorly understood. Here, we applied a genome-scale community metabolic modeling to build a personalized “digital microbiota” for analyzing the metabolic activity of gut microbes in 106 samples of Mexican prediabetic patients, distributed among patients without treatment and patients treated with metformin over baseline, 6 and 12 months. To contrast microbial metabolic activity across groups and explore how diet modulates it, we simulated computationally the microbial metabolic fluxes under Western, Mediterranean, and traditional Milpa diets across the three groups. As expected, in general terms in silico dietary intervention changes the metabolic responses in the microbiota profiles among the stages, suggesting specific combinations of diets that favor the production of relevant metabolites for wellness, such as amino sugars, short-chain fatty acids, and bile acid exchange fluxes. Furthermore, by selecting two individuals across the entire time as case studies, we provide a proof of concept for in silico personalized diet design. These examples illustrate how the concept of personalized digital microbiota could be leveraged to optimize dietary strategies and potentially improve outcomes in prediabetic patients.


  • Open Access

    MICOMWeb: a website for microbial community metabolic modeling of the human gut

    by Cristóbal Fresno, Juan José Oropeza-Valdez, Perla Itzel Alvarado-Luis, Patricia Peña-González, Armando R Tovar, Nimbe Torres, Christian Diener, Sean Gibbons, Osbaldo Resendis-Antonio

    MICOMWeb is a user-friendly website for modeling microbial community metabolism in the human gut. This website tackles three constraints when generating in silico metagenome-scale metabolic models: i) the prior Python user knowledge for metabolic modeling using flux balance analysis with the MICOM Python package, ii) predefined and user-defined diets to generate ad hoc metabolic models, and iii) the high-throughput computational infrastructure required to obtain the simulated growth and metabolic exchange fluxes, using real abundance from metagenomic shotgun or 16S amplicon sequencing; we present MICOMWeb's features to easily run in silico experiments as a functional hypothesis generator for experimental validation on three previously published databases. MICOMWeb has a constant run-time independent of the number of samples provided and database complexity. In practical terms, this behavior is upper-bounded by the sample with the greatest microbiota diversity, i.e., the sample with the largest metabolic reconstruction model size. The evidence suggests that the bigger the database, the better the MICOMWeb performs compared to MICOM in terms of consumed RAM (from 3.52 up to 7.13 folds) and total execution time (from 10.87 up to 205.05 folds).


  • Open Access

    Domain-Adversarial Neural Network and Explainable AI for Reducing Tissue-of-Origin Signal in Pan-cancer Mortality Classification

    by Cristian Padron-Manrique, Juan José Oropeza Valdez, Osbaldo Resendis-Antonio

    Tissue-of-origin signals dominate pan-cancer gene expression, often obscuring molecular features linked to patient survival. This hampers the discovery of generalizable biomarkers, as models tend to overfit tissue-specific patterns rather than capture survival-relevant signals. To address this, we propose a Domain-Adversarial Neural Network (DANN) trained on TCGA RNA-seq data to learn representations less biased by tissue and more focused on survival. Identifying tissue-independent genetic profiles is key to revealing core cancer programs. We assess the DANN using: (1) Standard SHAP, based on the original input space and DANN's mortality classifier; (2) A layer-aware strategy applied to hidden activations, including an unsupervised manifold from raw activations and a supervised manifold from mortality-specific SHAP values. Standard SHAP remains confounded by tissue signals due to biases inherent in its computation. The raw activation manifold was dominated by high-magnitude activations, which masked subtle tissue and mortality-related signals. In contrast, the layer-aware SHAP manifold offers improved low-dimensional representations of both tissue and mortality signals, independent of activation strength, enabling subpopulation stratification and pan-cancer identification of survival-associated genes.

  • Open Access

    MICOMWeb: a website for microbial community metabolic modeling of the human gut

    by Cristóbal Fresno, Juan José Oropeza-Valdez, Perla Itzel Alvarado-Luis, Patricia Peña-González, Armando R Tovar, Nimbe Torres, Christian Diener, Sean Gibbons, Osbaldo Resendis-Antonio

    Summary: MICOMWeb is a user-friendly website for easy microbial community metabolic modeling of the human gut. This website tackles three constraints when generating in silico metagenome-scale metabolic models: (i) the prior Python user knowledge for metabolic modeling using flux balance analysis with MICOM Python package, (ii) predefined and user-defined diets to generate ad hoc metabolic models, and (iii) the high- throughput computational infrastructure required to obtain the simulated growth and metabolic exchange fluxes, using real abundance from metagenomic shotgun or 16S amplicon sequencing; we present MICOMWeb’s features to easily run in silico experiments as a functional hypothesis generator for experimental validation on previously published data. Availability and Implementation: MICOMWeb is freely accessible for academic purposes at https://micomweb.c3.unam.mx .

  • Open Access

    Analyses of Saliva Metabolome Reveal Patterns of Metabolites That Differentiate SARS-CoV-2 Infection and COVID-19 Disease Severity

    by Violeta Larios-Serrato, Natalia Vázquez-Manjarrez, Osbaldo Resendis-Antonio, Nora Rios-Sarabia, Beatriz Meza, Oliver Fiehn, Javier Torres

    Background: The metabolome of COVID-19 patients has been studied sparsely, with most research focusing on a limited number of plasma metabolites or small cohorts. This is the first study to test saliva metabolites in COVID-19 patients in a comprehensive way, revealing patterns significantly linked to disease and severity, highlighting saliva’s potential as a non-invasive tool for pathogenesis or diagnostic studies. Methods: We included 30 asymptomatic subjects with no prior COVID-19 infection or vaccination, 102 patients with mild SARS-CoV-2 infection, and 61 hospitalized patients with confirmed SARS-CoV-2 status. Saliva samples were analyzed using hydrophilic interaction liquid chromatography–mass spectrometry (HILIC-MS/MS) in positive and negative ionization modes. Results: Significant differences in metabolites were identified in COVID-19 patients, with distinct patterns associated with disease severity. Dipeptides such as Val-Glu and Met-Gln were highly elevated in moderate cases, suggesting specific protease activity related to SARS-CoV-2. Acetylated amino acids like N-acetylserine and N-acetylhistidine increased in severe cases. Bacterial metabolites, including muramic acid and indole-3-carboxaldehyde, were higher in mild–moderate cases, indicating that oral microbiota differs according to disease severity. In severe cases, polyamines and organ-damage-related metabolites, such as N-acetylspermine and 3-methylcytidine, were significantly increased. Interestingly, most metabolites that were reduced in moderate cases were elevated in severe cases. Conclusions: Saliva metabolomics offers insightful information that is potentially useful in studying COVID-19 severity and for diagnosis.


  • Open Access

    AI-Driven Plant Health Assessment: A Comparative Analysis of Inception V3, ResNet-50 and ViT with SHAP for Accurate Disease Identification in Taro

    by Valeria Maeda-Gutiérrez, Juan José Oropeza-Valdez, Luis C. Reveles-Gómez, Cristian Padron-Manrique, Osbaldo Resendis-Antonio, Luis Octavio Solís-Sánchez, Hector A. Guerrero-Osuna, Carlos Alberto Olvera Olvera

    Early diagnosis and preventive measures are necessary to mitigate diseases’ impact on the yield of Colocasia esculenta (Taro). This study addresses the challenges of Taro disease identification by employing two key strategies: integrating explainable artificial intelligence techniques to interpret deep learning models and conducting a comparative analysis of advanced architectures Inception V3, ResNet-50, and Vision Transformers for classifying common Taro diseases, including leaf blight and mosaic virus, as well as identifying healthy leaves. The novelty of this work lies in the first-ever integration of SHapley Additive exPlanations (SHAP) with deep learning architectures to enhance model interpretability while providing a comprehensive comparison of state-of-the-art methods for this underexplored crop. The proposed models significantly improve the ability to recognize complex patterns and features, achieving high accuracy and robust performance in disease classification. The model’s efficacy was evaluated through multi-class statistical metrics, including accuracy, precision, F1 score, recall, specificity, Chohen’s kappa, and area under the curve. Among the architectures, Inception V3 exhibited superior performance in accuracy (0.9985), F1 score (0.9985), recall (0.9985), and specificity (0.9992). The explainability of Inception V3 was further enhanced using SHAP, which provides insights by dissecting the contributions of individual features in Taro leaves to the model’s predictions. This approach facilitates a deeper understanding of the disease classification process and supports the development of effective disease management strategies, ultimately contributing to improved Taro cultivation practices.


  • Open Access

    Intratumoral Heterogeneity and Metabolic Cross-Feeding in a Three-Dimensional Breast Cancer Culture: An In Silico Perspective

    by Jorge E. Arellano-Villavicencio, Aarón Vázquez-Jiménez, Juan José Oropeza-Valdez, Cristian Padron-Manrique, Heriberto Prado-García, Armando R. Tovar, Osbaldo Resendis-Antonio

    Today, the intratumoral composition is a relevant factor associated with the progression and aggression of cancer. Although it suggests a metabolic interdependence among the subpopulations inside the tumor, a detailed map of how this interdependence contributes to the malignant phenotype is still lacking. To address this issue, we developed a systems biology approach integrating single-cell RNASeq and genome-scale metabolic reconstruction to map the metabolic cross-feeding among the subpopulations previously identified in the spheroids of MCF7 breast cancer. By calibrating our model with expression profiles and the experimental growth rate, we concluded that the reverse Warburg effect emerges as a mechanism to optimize community growth. Furthermore, through an in silico analysis, we identified lactate, alpha-ketoglutarate, and some amino acids as key metabolites whose disponibility alters the growth rate of the spheroid. Altogether, this work provides a strategy for assessing how space and intratumoral heterogeneity influence the metabolic robustness of cancer, issues suggesting that computational strategies should move toward the design of optimized treatments.


  • Open Access

    Author Correction: Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes

    by Yoscelina Estrella Martínez-López, Daniel Neri-Rosario, Diego Armando Esquivel-Hernández, Cristian Padron-Manrique, Aarón Vázquez-Jiménez, Jean Paul Sánchez-Castañeda, David Girón-Villalobos, Cristian Mendoza-Ortíz, María de Lourdes Reyes-Escogido, Maria Lola Evia-Viscarra, et al.